Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Compensated Liver Disease (Disorder)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06773221
What this trial is testing

The Efficacy and Safety of Chiglitazar in Patients with MAFLD-related Cirrhosis

Who this might be right for
Metabolic Dysfunction Associated Fatty Liver DiseaseCompensated Liver Cirrhosis
Beijing Friendship Hospital 195
Not applicableUnknownNCT01148277
What this trial is testing

Propofol and Remifentanyl Versus Midazolam and Fentanyl for Diagnostic Colonoscopy in Patients With Compensated Cirrhosis Child A-B

Who this might be right for
Liver Disease
Ziv Hospital 90
Not applicableStudy completedNCT07687758
What this trial is testing

Non-Invasive Risk Stratification for Hepatocellular Carcinoma in HCV-Related Compensated Advanced Chronic Liver Disease Following Sustained Virological Response: Validation of the aMAP Score

Who this might be right for
Hepatitis C Virus InfectionCompensated Advanced Chronic Liver DiseaseHepatocellular Carcinoma (HCC)
Siriraj Hospital 571
Not applicableUnknownNCT04160897
What this trial is testing

Risk of Hepatocellular Carcinoma in Patients Treated With ETV vs TDF for Chronic Hepatitis B With Compensated Cirrhosis

Who this might be right for
Hepatitis B, ChronicHepatocellular CarcinomaCompensated Cirrhosis
Qing XIe 4,000
Large-scale testing (Phase 3)Ended earlyNCT01342705
What this trial is testing

Phlebotomy and Risk of Hepatocellular Carcinoma in Patients With Compensated Alcoholic Cirrhosis

Who this might be right for
Alcoholic CirrhosisIron Overload
Assistance Publique - Hôpitaux de Paris 17
Testing effectiveness (Phase 2)Ended earlyNCT00522808
What this trial is testing

The PK, Safety and Antiviral Activity of A-831 in HCV Carriers

Who this might be right for
Chronic Hepatitis C
Arrow Therapeutics 36
Post-approval studies (Phase 4)UnknownNCT05849558
What this trial is testing

Study to Compare the Efficacy & Safety of Ursoplus Capsules vs. UDCA vs. Placebo Among Chronic Liver Disease Patients

Who this might be right for
Chronic Liver Disease
MinaPharm Pharmaceuticals 297
Early research (Phase 1)Study completedNCT01909778
What this trial is testing

Open Label Single Dose Phase I Trial of BI 201335 to Study Pharmacokinetics and Safety in Patients With Compensated Liver Cirrhosis

Who this might be right for
Hepatitis CLiver Cirrhosis
Boehringer Ingelheim 2
Testing effectiveness (Phase 2)Study completedNCT01636778
What this trial is testing

Japanese Phase II Study of SB-497115-GR in Hepatitis C Virus Infected Patients

Who this might be right for
Hepatitis C, Chronic
GlaxoSmithKline 45
Large-scale testing (Phase 3)Study completedNCT01480284
What this trial is testing

Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B Untreated With Nucleic Acid Analogue

Who this might be right for
Hepatitis B, Chronic
GlaxoSmithKline 166
Large-scale testing (Phase 3)Ended earlyNCT03053063
What this trial is testing

Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis
Gilead Sciences 883
Large-scale testing (Phase 3)Study completedNCT03235349
What this trial is testing

Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With Compensated Cirrhosis and With or Without Human Immunodeficiency Virus Co-Infection

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 160
Testing effectiveness (Phase 2)Study completedNCT01516918
What this trial is testing

Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) in Subjects With Chronic Hepatitis C With Compensated Cirrhosis

Who this might be right for
Chronic Hepatitis C Virus
Vertex Pharmaceuticals Incorporated 103
Post-approval studies (Phase 4)Study completedNCT01088009
What this trial is testing

Efficacy Optimizing Research of Lamivudine Therapy

Who this might be right for
Compensated Chronic Hepatitis B
Nanfang Hospital, Southern Medical University 366
Early research (Phase 1)Looking for participantsNCT07553663
What this trial is testing

Evaluating the Pharmacokinetics and Safety of Miricorilant

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated CirrhosisMetabolic Dysfunction-associated Steatotic Liver Disease (MASLD)+1 more
Corcept Therapeutics
Not applicableNo Longer AvailableNCT01508286
What this trial is testing

Early Access Program of Telaprevir With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects

Who this might be right for
Hepatitis C
Janssen-Cilag International NV
Large-scale testing (Phase 3)Study completedNCT00304551
What this trial is testing

Peginterferon Alfa-2a in Combination With Ribavirin in Chronic Hepatitis C (CHC) Patients With Compensated Liver Cirrhosis (LC)

Who this might be right for
Liver CirrhosisChronic Hepatitis C
Chugai Pharmaceutical 180
Testing effectiveness (Phase 2)Study completedNCT06465186
What this trial is testing

A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)

Who this might be right for
Non-alcoholic Fatty Liver DiseaseNonalcoholic SteatohepatitisNAFLD+2 more
Merck Sharp & Dohme LLC 85
Large-scale testing (Phase 3)Study completedNCT02651194
What this trial is testing

Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Renally Impaired Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection

Who this might be right for
Chronic Hepatitis C Virus (HCV) Infection
AbbVie 104
Early research (Phase 1)Study completedNCT04950764
What this trial is testing

An Open-Label Study Following Oral Dosing of Seladelpar to Participants With Primary Biliary Cholangitis (PBC) and Hepatic Impairment (HI)

Who this might be right for
Primary Biliary CholangitisCompensated CirrhosisHepatic Impairment
Gilead Sciences 24
Next Page
15